A Program of Collaborative Care for Alzheimer's Disease
Study on the Efficacy of an Investigational Treatment for Chronic Pain
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Alzheimer's Disease
Age:
18 years - 100 years
Gender: All
Who can participate: Adults aged 18 to 65 years with a diagnosis of chronic pain for at least six months may be eligible to participate. Participants should not have any other significant medical conditions that could interfere with the study results.
Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular assessments of pain levels, physical function, and overall health. A placebo is a substance with no therapeutic effect used as a control in testing new drugs.
Updated on
19 Feb 2024.
Study ID: 0003-06 (1010002507)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
